高分辨率MRI评估他汀类药物对症状性颅内动脉粥样硬化的疗效
回顾性纳入2017年7月至2022年8月经HR-MRI确诊的症状性颅内动脉粥样硬化斑块患者48例,基线启动他汀治疗并随访至少3个月。他汀治疗>6个月(n=31)及血脂控制良好(n=21)的患者斑块长度、管壁厚度、斑块负荷、管腔狭窄及斑块强化均显著降低;HR-MRI可有效评估他汀治疗后的斑块变化。
要点
- 他汀治疗>6个月者斑块长度、管壁厚度、斑块负荷、管腔狭窄及斑块强化显著降低。
- 血脂控制良好者可见类似斑块获益,支持长期他汀治疗与良好血脂控制。
- 年轻、较低BMI及高血压与斑块负荷降低相关,较低BMI、高血压及更长他汀疗程与斑块强化降低相关。
核心结论
- HR-MRI可有效评估他汀治疗后的斑块变化,他汀可降低斑块负荷并稳定斑块,其疗效可能与年龄、BMI、高血压及他汀治疗时长有关。
研究设计与样本
- 回顾性研究,纳入2017年7月至2022年8月经3.0 T HR-MRI确诊的症状性颅内动脉粥样硬化斑块患者48例(男37例,总体平均年龄60.2±11.7岁),基线启动他汀治疗,随访至少3个月后复查HR-MRI。
关键影像表现/征象
- 他汀治疗>6个月(n=31)者斑块长度、管壁厚度、斑块负荷、管腔狭窄及斑块强化显著降低。
- 血脂控制良好(n=21)者亦见斑块长度、管壁厚度、斑块负荷、管腔狭窄及斑块强化显著降低。
- 年轻、较低BMI及高血压与斑块负荷降低相关(均p<0.05)。
- 较低BMI、高血压及更长他汀疗程与斑块强化降低相关(均p<0.05)。
- 年轻及高血压与管腔狭窄降低相关(均p<0.05)。
临床应用与阅片要点
- HR-MRI可作为症状性颅内动脉粥样硬化随访的有效方法,用于评估他汀治疗后的斑块特征变化。
- 长期他汀使用及良好控制的血脂水平有助于降低斑块负荷并稳定斑块。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the efficacy of statins on symptomatic intracranial atherosclerotic plaques using high-resolution 3.0 T MR vessel wall imaging (HR-MRI).
METHODS: Patients with symptomatic intracranial atherosclerotic plaques (cerebral ischemic events within the last three months) confirmed by HR-MRI from July 2017 to August 2022 were retrospectively included in this study. The enrolled patients started statin therapy at baseline. All the patients underwent the follow-up HR-MRI examination after statin therapy for at least 3 months. A paired sample t-test and Wilcoxon rank sum test were used to evaluate the changes in plaque characteristics after statin therapy. Multivariate linear regression was further used to investigate the clinical factors associated with statin efficacy.
RESULTS: A total of 48 patients (37 males; overall mean age = 60.2 ± 11.7 years) were included in this study. The follow-up time was 7.0 (5.6-12.0) months. In patients treated with statins for > 6 months (n = 31), plaque length, wall thickness, plaque burden, luminal stenosis and plaque enhancement were significantly reduced. Similar results were found in patients with good lipid control (n = 21). Younger age, lower BMI and hypertension were associated with decreased plaque burden. Lower BMI, hypertension and longer duration of statin therapy were associated with decreased plaque enhancement. Younger age and hypertension were associated with decreased luminal stenosis (all p < 0.05).
CONCLUSION: HR-MRI can effectively evaluate plaques changes after statin therapy. Statins can reduce plaque burden and stabilize plaques. The effect of statin may have a relationship with age, BMI, hypertension, and duration of statin therapy.
CLINICAL RELEVANCE STATEMENT: High-resolution MRI can be applied to evaluate the efficacy of statins on symptomatic intracranial atherosclerotic plaques. Long-term statin use and well-controlled blood lipid levels can help reduce plaque burden and stabilize plaques.
KEY POINTS: High-resolution MRI provides great help evaluating the changes of plaque characteristics after statin therapy. Efficacy of statins is associated with duration of use, controlled lipid levels, and clinical factors. High-resolution MRI can serve as an effective method for following-up symptomatic intracranial atherosclerosis.
引用
- Huang J, Liu C, Jiao S, et al. Application of high-resolution MRI in evaluating statin efficacy on symptomatic intracranial atherosclerosis. Eur Radiol. 2024. PMID: 39030372. doi:10.1007/s00330-024-10968-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。